Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 13,801-13,812 of 23,847
Drug study icon
CompletedNCT00120250

Eszopiclone for Sleep Disturbance and Nightmares in PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Boston
PTSDDrugA study involving a medication or substance.From 18 Years to 64 Years
Countries
United States
Sponsor
Massachusetts General Hospital
Condition
PTSD
Behavioral study icon
CompletedNCT01605253

Eszopiclone for PTSD

This summary needs review. Please check the official study record and contact the research team for details.

In Chicago
PTSDBehavioralFrom 18 Years to 65 Years
Countries
United States
Sponsor
Rush University Medical Center
Condition
PTSD
Other study type icon
CompletedNCT06790849

ETASCAI Project

This summary needs review. Please check the official study record and contact the research team for details.

In Reading
AnxietyOtherFrom 60 Years to 80 Years
Countries
United Kingdom
Sponsor
University of Reading
Condition
Anxiety
Drug study icon
CompletedNCT00634361

Ethyl-EPA Treatment of Prodromal Patients

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
SchizophreniaDrugFrom 14 Years to 35 Years
Countries
Sponsor
Yale University
Condition
Schizophrenia
Behavioral study icon
CompletedNCT02542891

European Comparative Effectiveness Research on Internet-based Depression Treatment

This study exists to compare options and see whether cognitive behavioural therapy, a structured talking treatment, offers something meaningfully different. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Bordeaux
DepressionBehavioralOver 18 Years
Countries
France
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France
Condition
Depression
Behavioral study icon
CompletedNCT01331330

European Deep Brain Stimulation (DBS) Depression Study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Nice
DepressionBehavioralFrom 21 Years to 70 Years
Countries
France, United Kingdom, Israel
Sponsor
Abbott Medical Devices
Condition
Depression
Drug study icon
CompletedNCT02146547

European Long-acting Antipsychotics in Schizophrenia study

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Innsbruck
SchizophreniaDrugOver 18 Years
Countries
United Kingdom, Belgium, Austria, ...
Sponsor
UMC Utrecht
Condition
Schizophrenia
Drug study icon
Enrolling By InvitationNCT05165316

European Long-acting Antipsychotics in Schizophrenia study-II

This observational study is following people with Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Ramat Gan
SchizophreniaOtherOver 18 Years
Countries
Israel
Sponsor
Rene Kahn
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.